Results 21 to 30 of about 1,610 (149)
Management of patients with vulvovaginal atrophy and cytological abnormalities
Гинекология, 2023 The data on managing patients with vulvovaginal atrophy and abnormal cytological results are provided for obstetrician-gynecologists.
Niso M. Nazarova +5 more
doaj +1 more source
Current management of vaginal dryness [PDF]
РМЖ. Мать и дитя, 2021 T.V. Tazina1, A.V. Knyazeva2, T.V. Bebneva3,4 1Ryazan State Medical University, Ryazan, Russian Federation 2Regional Clinical Hospital, Ryazan, Russian Federation 3Russian University of Peoples’ Friendship, Moscow, Russian Federation ...
T.V. Tazina, A.V. Knyazeva, T.V. Bebneva
doaj +2 more sources
European Medical Journal Urology, 2020 Objective: Vaginal atrophy, vulvovaginal dystrophy, and stress urinary incontinence (SUI), common conditions in women, have detrimental effects on quality of life.
Laura Stark +5 more
doaj +1 more source
Medical and Health Science Journal, 2020 Background : Vulvovaginal atrophy is a condition that often occurs in menopausal women due to Estrogen decreased. Prasterone (DHEA) is a steroid hormone that can be converted into Estrogen in the target tissue.
Zettira Maulida Prasha, Hari Paraton
doaj +1 more source
Гинекология, 2023 Hypoestrogenism associated with menopause has a strong negative effect on the condition of the vagina and urinary tract, and often leads to the development of genitourinary menopausal syndrome, significantly disrupting the quality of life of women ...
Liana Z. Ziganshina +3 more
doaj +1 more source
Women’s Sexual Dysfunctions Following Stem Cell Transplant and the Impact on Couple Relationship
Life, 2023 Stem cell transplant proved its efficacy in increasing the survival rate among young patients diagnosed with hematological malignancies. A transplant conditioning regimen is particularly destructive on the genital system, often determining premature ...
Mihaela Plotogea +11 more
doaj +1 more source
Vulvovaginal atrophy in the peri- and post-menopause: relevance and impact on quality of life [PDF]
Гинекология, 2022 Vulvovaginal atrophy (VVA) is detected in more than 50% of postmenopausal women, and at 4049 years of age, 15-19% of women have relevant signs. Atrophic changes in the female urogenital system are associated with hypoestrogenism, which results in the ...
Mekan R. Orazov +5 more
doaj +1 more source
Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy
Gynecological Endocrinology, 2021 It is estimated that 50% of women will suffer a severe form of vulvovaginal atrophy (VVA) related to menopause. Equally, young women may temporarily present this clinical problem while receiving various pharmacological or endocrine treatments or radiotherapy.To determine clinical and diagnostic exams required to confirm the presence of VVA (also ...
Faustino R. Pérez-López +5 more
openaire +2 more sources
Diagnostics and management of vulvovaginal atrophy according to the international guidelines
Фундаментальная и клиническая медицина, 2022 Vulvovaginal atrophy is one of the genitourinary symptoms caused by estrogen deficiency which leads to the development of immature vaginal epithelium, glycogen deficiency, reduction or even elimination of lactobacilli, and secondary genitourinary tract ...
K. V. Dmitrienko +2 more
doaj +1 more source
Efficacy of laser remodeling in the genitourinary syndrome of menopause: A review
Гинекология, 2023 The real-world treatment of genitourinary syndrome of menopause has several limitations: contraindications to topical estrogen therapy, which is currently recognized as the "gold standard" treatment for vulvovaginal atrophy (VVA), fear of the systemic ...
Mekan R. Orazov +5 more
doaj +1 more source